The Food and Drug Administration has concluded that no child deaths have been definitively linked to COVID-19 vaccines, according to a report made public last week.

The FDA analysis represents the agency's assessment of safety data collected since pediatric COVID-19 vaccinations began. The report was released without fanfare, appearing on the agency's website as part of routine regulatory documentation.

The findings come as vaccine safety continues to be monitored across all age groups, with particular attention paid to pediatric populations due to heightened parental concerns. The FDA has maintained ongoing surveillance systems to track adverse events following vaccination.

COVID-19 vaccines for children were authorized under emergency use provisions, with the FDA requiring extensive safety monitoring as a condition of approval. The agency has previously stated that serious adverse events in children remain rare.

The report adds to the growing body of safety data on pediatric COVID-19 vaccinations, though vaccine hesitancy remains a concern among some parents and healthcare providers.